Go Pro

First Tracks Biotherapeutics (TRAX) Institutional Ownership

$33.28 -0.64 (-1.89%)
Closing price 04:00 PM Eastern
Extended Trading
$33.31 +0.03 (+0.09%)
As of 05:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for First Tracks Biotherapeutics (NASDAQ:TRAX)

Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$34.37M
Number of
Institutional Sellers
(last 12 months)
0
Get TRAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling First Tracks Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TRAX Institutional Buying and Selling by Quarter

First Tracks Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/22/2026State Street Corp1,512,896$30.44M0.0%N/A4.234%
9/9/2026Opaleye Management Inc.65,000$1.31M0.1%N/A0.182%
9/9/2026Tidal Investments LLC30,907$622K0.0%N/A0.086%
8/27/2026Corient Private Wealth LP30,339$610K0.0%N/A0.085%
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al11,550$232K0.0%N/A0.032%
8/19/2026Wellington Management Group LLP57,476$1.16M0.0%N/A0.161%


TRAX Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of First Tracks Biotherapeutics shares: State Street Corp ($30.44M), Opaleye Management Inc. ($1.31M), Wellington Management Group LLP ($1.16M), Tidal Investments LLC ($622K), and Corient Private Wealth LP ($610K), VIRGINIA RETIREMENT SYSTEMS ET Al ($232K).Learn more on First Tracks Biotherapeutics' institutional investors.

The following institutional investors have purchased First Tracks Biotherapeutics' stock in the last 24 months: State Street Corp ($1.51M), Opaleye Management Inc. ($65K), Wellington Management Group LLP ($57.48K), Tidal Investments LLC ($30.91K), Corient Private Wealth LP ($30.34K), and VIRGINIA RETIREMENT SYSTEMS ET Al ($11.55K).

Institutional investors have bought a total of 1,708,168 shares in the last 24 months. This purchase volume represents approximately $34.37M in transactions.



Institutional ownership data for NASDAQ:TRAX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/22/2026. New 13F filings are added each quarter as they're published.
From Our Partners